Infant formulas for special medical purposes (iFSMPs).


Please note, you are able to place an order with a maximum samples value of 12 across different product types and flavours. You are limited to ordering a maximum of two tins of our allergy products per order: Alimentum and EleCare.


IMPORTANT NOTICE: Breastfeeding is best for infants and is recommended for as long as possible during infancy. Alimentum and EleCare are infant formulas for special medical purposes and should only be used under the recommendation or guidance of a healthcare professional.

*The International Milk Allergy in Primary Care (iMAP) guideline recommends breastfeeding as the first-line option in infants with CMA.15
The 2'-FL (2'-fucosyllactose) used in this formula is biosynthesised and structurally identical to the human milk oligosaccharide (HMO) 2'-FL, found in most mothers' breast milk.1
MIMS. July 2021.
§Studies conducted in healthy-term infants consuming standard Similac formula with 2’-FL (not Alimentum or EleCare), compared with control formula without 2’-FL.
Parent reports from a single-arm study, where all infants were consuming an extensively hydrolysed formula before being switched to Alimentum with 2’-FL for 60 days. After 7 days of switching to Alimentum with 2’-FL, the majority of parents reported that the following symptoms had improved or resolved: 84% of infants with constipation, 71% of infants with eczema, 100% of infants with vomiting.8
**Studies conducted in infants fed standard EleCare formula without 2’-FL.
††Price per 100ml when made up using standard concentration.
CMA: cow’s milk allergy; HMO: human milk oligosaccharide.

References: 1. Reverri EJ, et al. Nutrients. 2018;10(10):1346. 2. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649–658. 3. Goehring KC, et al. J Nutr. 2016;146(12):2559–2566. 4. Borschel MW, et al. Clin Pediatr (Phila). 2013;52(10):910–917. 5. Borschel MW, et al. BMC Pediatr. 2014;14:136.
6. Sicherer SH, et al. J Pediatr. 2001;138:688–693. 7. Borschel MW, et al. SAGE Open Med. 2014;2:2050312114551857. 8. Abbott. Data on File (AL32). April 2020. 9. Borschel MW. Allergy. 2014; 69(Suppl. 99):454–572. 10. Sampson HA, et al. J Pediatr. 1991;118(4 Pt 1):520–525. 11. RTI research. Abbott EleCare No.1 Dr Recommended. Final Results. 2019. 12. Abbott. EleCare Promotional Claims Parent Survey. 2019. 13. Abbott. UK Alimentum Market Research. 2018. 14. Erney RM, et al. J Pediatr Gastroenterol Nutr. 2000;30(2):181–192. 15. Fox A, et al. Clin Transl Allergy. 2019;9:40. 16. Health Foundation. Non-COVID-19 NHS care during the pandemic. Available at: (accessed July 2021). 17. MIMS. July 2021.